Japanese firm Takeda Pharmaceutical has announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program, which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries (in Low and Middle Income Countries- LMICs).

JPY 953 million is being committed to IntraHealth International to work with 12 private schools in Mali, Senegal and Niger to increase the number of qualified, trained nurses who can serve rural communities facing a critical shortage of health workers in these countries.

JPY 890 million is being provided to Jhpiego’s iWIN project, to help accelerate progress in preventing maternal and newborn mortality and morbidity by mending the fragmented maternal and child health ecosystem in India via a holistic, woman-centered approach.

With JPY 1 billion being given to Pathfinder International, the objective is to advance women’s and girls’ leadership in responding to the disproportionate impact of climate change and emergencies on women’s health. Operating in South and Southeast Asia over four years, the project will position women and girls as change agents in places where gender inequalities and climate-related crises reduce their quality of health.

JPY 1.3 billion to the World Food Programme’s Project Boreas, over the next five years, will enhance the capacity of the United Nations Humanitarian Response Depot in Accra, Ghana, to more efficiently receive, store and transport temperature-sensitive health products in 17 countries in West Africa